Research Scientist (Oncology / Immuno-Oncology)

Eurofins · Bengaluru, KA

$0k – $0k/yrPosted Jun 2, 2026

Eurofins Advinus is a premier preclinical and early development CRO offering drug discovery, preclinical and development stage contract research services in the areas of discovery services, regulatory Toxicology (Safety Assessment), DMPK, Analytical R&D Services and API CDMO. Eurofins Advinus manufactures drug substances to support Toxicology and early clinical studies.

With over 30 years of GLP compliance and certification, Eurofins Advinus serves diverse industries such as Biotech, Pharmaceutical, Biological, Agrochemical, Nutraceutical and Cosmetic. Eurofins Advinus is the only contract research organization (CRO) in India to have developed data in support of 90+ end-to-end IND enabling packages to be submitted to global regulators such as USFDA, EMA, MHRA, Health Canada and others.

We are looking for passionate and talented professionals to join our growing research team.

📍 Location: Bangalore

🔬 Requirements:

M.Pharm (Pharmacology)

2–3 years of experience in Oncology / Immuno-Oncology

Hands-on experience in Cell Culture is preferred

Strong understanding of preclinical research and experimental techniques

Good analytical, documentation, and communication skills

🌟 This is an excellent opportunity to work on cutting-edge research programs in the Oncology and Immuno-Oncology space and contribute to innovative drug discovery initiatives.

📩 Interested candidates can share their updated resume with me or reach out directly for more details.

#Hiring #MPharm #Pharmacology #Oncology #ImmunoOncology #CellCulture #ResearchAssociate #DrugDiscovery #LifeSciences #PharmaJobs #BangaloreJobs #HiringNow

📩 Interested candidates may send their CV to:

hr.hiring@bpin.eurofinsasia.com

🔁 Feel free to share or refer suitable candidates in your network.

Originally posted by Eurofins. View original posting

← Browse all companies

BioCareerAI is an independent job platform and is not affiliated with or endorsed by Eurofins.